Glycation and Advanced Glycation End-Products (AGEs)

Glycation is one of the chemical processes by which biological molecules change over time without the involvement of enzymes. In ageing research, the main interest is not the initial sugar attachment by itself, but the later formation of advanced glycation end-products, or AGEs, which can alter tissue mechanics, protein function, and cell signaling. [1] [2] [3]

Who This Is Useful For

This page is useful for readers trying to place glycation within the wider biology of ageing rather than viewing it only through the lens of diabetes. It is especially relevant for people who encounter claims about AGEs, tissue stiffness, inflammation, or "sugar damage" and want a more precise account of what is known and what remains uncertain.

What Glycation Means

Glycation refers to non-enzymatic reactions between reducing sugars or related reactive carbonyl species and biological macromolecules. Early products such as Schiff bases and Amadori rearrangement products can undergo further oxidation, dehydration, and crosslinking reactions, eventually producing a heterogeneous group of compounds collectively called AGEs. [2] [3]

Where AGEs Come From

AGE formation occurs endogenously as part of normal metabolism, especially when reactive carbonyl intermediates persist long enough to modify proteins and other targets. AGEs can also enter the body from exogenous sources including heat-processed foods and tobacco smoke, although the biological impact of exogenous AGEs depends on absorption, metabolism, and tissue context. [2] [4] [5]

Why AGEs Accumulate With Age

AGE accumulation is especially relevant in long-lived proteins with slow turnover, such as collagen in extracellular matrix. When proteins remain in place for years, there is more time for non-enzymatic modification and crosslink formation, which helps explain why AGE burden can rise even outside overt metabolic disease. Reviews of ageing phenotypes and collagen chemistry emphasize that turnover rate is a major determinant of AGE accumulation. [5] [6] [7]

Structural Effects in Tissues

One major consequence of AGE formation is structural change in extracellular proteins. Crosslinking can increase stiffness, reduce elasticity, and make collagen networks less amenable to normal remodeling. These effects are relevant to skin, blood vessels, cartilage, and other tissues where matrix mechanics help determine function. [1] [6] [7]

This is one reason AGEs are often discussed in relation to visible and functional ageing. The concept is not that AGEs explain all age-related decline, but that they can contribute to the gradual loss of tissue compliance and repair capacity in long-lived structures. [1] [5]

Signaling Effects Through RAGE

AGEs are not only passive chemical damage markers. Several AGE species can bind the receptor for advanced glycation end-products, usually called RAGE, and activate signaling pathways linked to oxidative stress, inflammatory gene expression, and vascular dysfunction. This matters for ageing biology because AGE burden may influence both tissue structure and cell-to-cell signaling at the same time. [3] [8] [9]

AGE Biology at a Glance

Why AGEs Are Relevant Beyond Diabetes

AGEs are often discussed in diabetes because hyperglycemia accelerates glycation chemistry, but the process is not limited to diabetic states. Ageing tissues can accumulate AGEs gradually under ordinary metabolic conditions, particularly where protein turnover is slow and oxidative stress is persistent. This is why AGEs are studied as part of general age-related tissue change as well as metabolic disease. [2] [5] [6]

Evidence Quality and Interpretation

Confidence is strong that AGE accumulation occurs with age in many tissues and that AGE crosslinks can alter the physical properties of long-lived proteins. There is also substantial mechanistic evidence that AGE-RAGE interactions can amplify inflammatory and oxidative signaling. [5] [6] [7] [8]

Confidence is weaker when AGEs are framed as a single dominant explanation for organism-level ageing. Ageing involves multiple interacting processes, and AGE biology overlaps with broader mechanisms such as inflammation, extracellular matrix remodeling, and metabolic dysregulation rather than replacing them. [5] [8] [10]

What This Does Not Mean

• It does not mean all sugars are biologically equivalent to AGE damage.
• It does not mean AGE measurements from one tissue automatically describe whole-body ageing.
• It does not mean glycation is only relevant in diabetes; it also occurs during ordinary ageing.
• It does not mean AGEs alone explain age-related decline across every organ system.

Practical Interpretation Examples

• If a tissue becomes stiffer with age: AGE crosslinking is one plausible contributor, especially in long-lived extracellular matrix, but not the only one.
• If an AGE biomarker is elevated: That may indicate higher glycation burden in a given context, not a complete measure of biological ageing.
• If inflammation and AGE accumulation appear together: The relationship may be bidirectional through pathways such as RAGE rather than a simple one-step causal chain.

Related Reading

• Proteostasis and Ageing
• Intercellular Communication and Ageing
• Hallmarks of Ageing
• Why Ageing Is Not a Single Process

Summary

Glycation is a slow, non-enzymatic source of molecular change that becomes more important over time, especially in long-lived tissues. AGEs matter in ageing research because they can both reshape tissue mechanics and activate inflammatory signaling, making them a useful example of how chemical damage and biological response become linked during ageing. [1] [5] [8]

References

1. Gkogkolou, P., & Bohm, M. (2012). Advanced glycation end products: Key players in skin aging? Dermato-Endocrinology. https://pmc.ncbi.nlm.nih.gov/articles/PMC3583881/
2. Singh, R., Barden, A., Mori, T., & Beilin, L. (2001). Advanced glycation end-products: a review. Diabetologia. https://link.springer.com/article/10.1007/s001250051591
3. Kuzan, A. (2021). Toxicity of advanced glycation end products (Review). Biomedical Reports. https://pmc.ncbi.nlm.nih.gov/articles/PMC8538825/
4. Uribarri, J., Woodruff, S., Goodman, S., et al. (2010). Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet. Journal of the American Dietetic Association. https://pmc.ncbi.nlm.nih.gov/articles/PMC3704564/
5. Semba, R. D., Nicklett, E. J., & Ferrucci, L. (2010). Does accumulation of advanced glycation end products contribute to the aging phenotype? The Journals of Gerontology Series A. https://pmc.ncbi.nlm.nih.gov/articles/PMC3011572/
6. Verzijl, N., DeGroot, J., Thorpe, S. R., et al. (2000). Effect of collagen turnover on the accumulation of advanced glycation end products. Journal of Biological Chemistry. https://pubmed.ncbi.nlm.nih.gov/10723044/
7. Verzijl, N. et al. (2002). Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage. Arthritis & Rheumatism. https://pubmed.ncbi.nlm.nih.gov/11822407/
8. Ramasamy, R., Vannucci, S. J., Yan, S. S. D., Herold, K., Yan, S. F., & Schmidt, A. M. (2005). Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology. https://pubmed.ncbi.nlm.nih.gov/15764693/
9. Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014). Role of advanced glycation end products in cellular signaling. Redox Biology. https://pmc.ncbi.nlm.nih.gov/articles/PMC3966449/
10. Lopez-Otin, C. et al. (2023). Hallmarks of aging: An expanding universe. Cell. https://pmc.ncbi.nlm.nih.gov/articles/PMC10809922/